Arkema's Shares Fall 5.6% at Close on January 16
The French chemical company ended sharply lower this Friday, dropping 5.6% to 50.55 euros. The stock is moving in an environment characterized by target price revisions and a tense technical context.
Significant Drop in Arkema's Shares
Arkema's shares closed with a marked decline of 5.6% at 50.55 euros, erasing the gains from the previous session which had brought it to 53.55 euros. The stock has struggled for the sixth time since mid-October against the upper boundary of its consolidation channel at 53.60 euros, leading to a technical pullback towards 50 euros. The crucial support threshold at 50.35 euros is now threatened, while the 50-day moving average is at 51.72 euros. The RSI is at 65 points, still leaving some margin before the overbought zone but already indicating significant technical pressure. Over the past year, the stock has suffered a loss of 31.74%, reflecting a challenging stock market environment for the specialty chemicals sector. This technical weakness occurs as the 200-day moving average at 58.30 euros remains significantly above the current price, illustrating the lack of sustained bullish momentum. The traded volumes representing 0.55% of the capital indicate moderate activity in this weekly closing session.
Mixed Views from Analysts on Arkema
The Arkema case has seen divergent views from analysts. Last Tuesday, UBS revised its price target from 64 to 61 euros while maintaining its buy recommendation, suggesting a potential upside of 20.7% from the current price. At the same time, JP Morgan reduced its target from 55 to 50 euros with a neutral opinion, reflecting increased caution about the chemist's prospects. These adjustments follow Morgan Stanley's earlier reduction in early January from 90 to 78 euros, while still maintaining its overweight recommendation. Operationally, the group announced on January 13 the commissioning of a new production unit for Rilsan Clear transparent polyamide in Singapore, tripling its global capacity in this segment. This industrial expansion is part of the group's strategy to move upmarket, while the divestiture of impact modifiers activities to the Indian group Praana, unveiled at the end of December, illustrates the refocusing of the business portfolio on higher value-added specialties.
